Schonfeld Strategic Advisors LLC Has $241,000 Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC)

Schonfeld Strategic Advisors LLC lessened its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 75.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,300 shares of the medical technology company's stock after selling 82,356 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Alphatec were worth $241,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ATEC. R Squared Ltd acquired a new stake in shares of Alphatec in the 4th quarter valued at $29,000. Nisa Investment Advisors LLC increased its stake in shares of Alphatec by 973.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 4,669 shares of the medical technology company's stock valued at $43,000 after buying an additional 4,234 shares during the period. Quarry LP increased its stake in shares of Alphatec by 79.2% in the 4th quarter. Quarry LP now owns 5,374 shares of the medical technology company's stock valued at $49,000 after buying an additional 2,375 shares during the period. Newton One Investments LLC acquired a new stake in shares of Alphatec in the 4th quarter valued at $50,000. Finally, AlphaQuest LLC acquired a new stake in shares of Alphatec in the 4th quarter valued at $80,000. Institutional investors own 66.35% of the company's stock.

Insider Activity

In related news, COO Scott Lish sold 12,000 shares of the company's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $12.12, for a total transaction of $145,440.00. Following the sale, the chief operating officer now owns 826,251 shares in the company, valued at approximately $10,014,162.12. This represents a 1.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP David Sponsel sold 12,946 shares of the company's stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $10.73, for a total value of $138,910.58. Following the sale, the executive vice president now owns 722,128 shares in the company, valued at $7,748,433.44. The trade was a 1.76% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 126,945 shares of company stock worth $1,416,352 over the last three months. Corporate insiders own 20.90% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on ATEC shares. Needham & Company LLC reaffirmed a "buy" rating and set a $16.00 price objective on shares of Alphatec in a research note on Friday, May 2nd. HC Wainwright reaffirmed a "buy" rating and set a $20.00 price objective on shares of Alphatec in a research note on Monday, April 14th. Barclays lifted their price objective on Alphatec from $20.00 to $21.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 22nd. Piper Sandler reaffirmed an "overweight" rating and set a $15.00 price objective (up from $13.00) on shares of Alphatec in a research note on Friday, May 2nd. Finally, StockNews.com raised Alphatec from a "sell" rating to a "hold" rating in a research note on Friday, February 28th. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $17.89.

Alphatec Trading Up 1.7%

NASDAQ:ATEC traded up $0.22 on Friday, reaching $12.96. The company's stock had a trading volume of 1,528,655 shares, compared to its average volume of 2,035,745. Alphatec Holdings, Inc. has a 1-year low of $4.88 and a 1-year high of $13.03. The company has a debt-to-equity ratio of 30.21, a quick ratio of 1.15 and a current ratio of 2.32. The firm has a market cap of $1.89 billion, a PE ratio of -10.13 and a beta of 1.06. The business's 50-day moving average price is $10.73 and its two-hundred day moving average price is $10.35.

Alphatec (NASDAQ:ATEC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.23). The firm had revenue of $169.18 million during the quarter, compared to the consensus estimate of $167.57 million. Alphatec had a negative net margin of 31.06% and a negative return on equity of 541.39%. The business's revenue for the quarter was up 22.2% on a year-over-year basis. During the same quarter last year, the firm earned ($0.34) earnings per share. Equities research analysts anticipate that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current fiscal year.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.